191 – 200 of 303
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).
- Contribution to journal › Article
-
Mark
Reaching beyond HIV/HCV: nelfinavir as a potential starting point for broad-spectrum protease inhibitors against dengue and chikungunya virus
- Contribution to journal › Article
-
Mark
Chapter 9: Evidence based pharmacy for developing countries
- Contribution to journal › Article
-
Mark
Chapter 12: Evidence-based skills and practices for the future of pharmacy
- Contribution to journal › Article
-
Mark
Molecularly Imprinted Polymer Nanocarriers for Sustained Release of Erythromycin.
- Contribution to journal › Article
-
Mark
Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
- Contribution to journal › Scientific review
-
Mark
Chapter 8: Generating knowledge
- Contribution to journal › Article
-
Mark
Virtual screening for identifying a putative inhibitor of rmlc, a major target protein in tuberculosis disease
- Contribution to journal › Article
- 2014
-
Mark
Opioids for Chronic Refractory Breathlessness: Right Patient, Right Route?
- Contribution to journal › Article
-
Mark
Epigenetic adaptation to regular exercise in humans.
- Contribution to journal › Scientific review
